Cumberland Pharmaceuticals CPIX
$ 1.08
-3.57%
Quarterly report 2024-Q3
added 11-08-2024
Cumberland Pharmaceuticals Balance Sheet 2011-2024 | CPIX
Annual Balance Sheet Cumberland Pharmaceuticals
2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-15 M | -26 M | -7.57 M | -6.72 M | 352 K | -30.9 M | -14.8 M | -21.9 M | -39.9 M | -40.9 M | -33.3 M | -65.7 M |
Long Term Debt |
4.59 M | 90 K | 15 M | 18.5 M | 20 M | 9.8 M | 4.1 M | 1.7 M | - | - | 4.36 M | 4.86 M |
Long Term Debt Current |
173 K | 970 K | 1.02 M | 920 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | 23.9 M | 29.3 M | 29.3 M | 11.6 M | 5.49 M | 2.69 M | 903 K | 776 K | 4.97 M | 6.08 M |
Total Current Liabilities |
28.6 M | 19.3 M | 25.7 M | 24.2 M | 27.8 M | 17.7 M | 14.8 M | 12.4 M | 13.7 M | 7.55 M | 8.06 M | 6.6 M |
Total Liabilities |
57 M | 41.9 M | 49.6 M | 53.5 M | 57.1 M | 29.3 M | 20.3 M | 15.1 M | 14.7 M | 8.32 M | 13 M | 12.7 M |
Deferred Revenue |
615 K | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-11.2 M | -5.64 M | -2.13 M | 1.21 M | 4.75 M | 11.7 M | 18.6 M | 19.5 M | 18.8 M | 16.4 M | 18.5 M | 12.7 M |
Total Assets |
92.9 M | 84.5 M | 96.5 M | 105 M | 113 M | 93.2 M | 93.4 M | 91.9 M | 95.4 M | 87.6 M | 98.6 M | 95.5 M |
Cash and Cash Equivalents |
19.8 M | 27 M | 24.8 M | 28.2 M | 27.9 M | 45.4 M | 34.5 M | 38.2 M | 39.9 M | 40.9 M | 54.3 M | 70.6 M |
Book Value |
36 M | 42.6 M | 46.9 M | 51.1 M | 55.6 M | 63.9 M | 73.1 M | 76.8 M | 80.8 M | 79.3 M | 85.6 M | 82.8 M |
Total Shareholders Equity |
36.3 M | 42.8 M | 47 M | 51.1 M | 55.8 M | 64.1 M | 73.2 M | 76.9 M | 80.8 M | 79.5 M | 85.7 M | 82.9 M |
All numbers in USD currency
Quarterly Balance Sheet Cumberland Pharmaceuticals
2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
5 M | 5.1 M | 5.3 M | 5.39 M | 5.48 M | 4.55 M | 4.59 M | - | - | 22.7 K | 90 K | 230 K | 512 K | 789 K | 1.06 M | 1.06 M | 1.06 M | 1.06 M | 2.08 M | 2.32 M | 2.08 M | 2.61 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
52.3 M | 52.5 M | 52.5 M | 52.1 M | 52.5 M | 53.4 M | 57 M | 52.3 M | 53.3 M | 55.9 M | 41.9 M | 40.9 M | 41 M | 46.5 M | 49.6 M | 49.6 M | 49.6 M | 49.6 M | 53.5 M | 52.1 M | 53.5 M | 59.4 M | 57.1 M | 57.1 M | 57.1 M | 57.1 M | 29.3 M | 29.3 M | 29.3 M | 29.3 M | 20.3 M | 20.3 M | 20.3 M | 20.3 M | 15.1 M | 15.1 M | 15.1 M | 15.1 M | 14.7 M | 14.7 M | 14.7 M | 14.7 M | 8.32 M | 8.32 M | 8.32 M | 8.32 M | 13 M | 13 M | 13 M | 13 M | 12.7 M | 12.7 M | 12.7 M | 12.7 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-22.1 M | -20.5 M | -17.5 M | -11.2 M | -10.1 M | -11 M | -11.2 M | -8.77 M | -8.36 M | -7.02 M | -5.64 M | -1.79 M | -736 K | -1.96 M | -2.13 M | -2.13 M | -2.13 M | -2.13 M | 1.21 M | 2.17 M | 1.21 M | 4.67 M | 4.75 M | 4.75 M | 4.75 M | 4.75 M | 11.7 M | 11.7 M | 11.7 M | 11.7 M | 18.6 M | 18.6 M | 18.6 M | 18.6 M | 19.5 M | 19.5 M | 19.5 M | 19.5 M | 18.8 M | 18.8 M | 18.8 M | 18.8 M | 16.4 M | 16.4 M | 16.4 M | 16.4 M | 18.5 M | 18.5 M | 18.5 M | 18.5 M | 12.7 M | 12.7 M | 12.7 M | 12.7 M |
Total Assets |
76.7 M | 78.5 M | 81.8 M | 87.8 M | 89.4 M | 89.5 M | 92.9 M | 90.8 M | 92.5 M | 96.7 M | 84.5 M | 87.6 M | 88.9 M | 93.3 M | 96.5 M | 96.5 M | 96.5 M | 96.5 M | 105 M | 104 M | 105 M | 115 M | 113 M | 113 M | 113 M | 113 M | 93.2 M | 93.2 M | 93.2 M | 93.2 M | 93.4 M | 93.4 M | 93.4 M | 93.4 M | 91.9 M | 91.9 M | 91.9 M | 91.9 M | 95.4 M | 95.4 M | 95.4 M | 95.4 M | 87.6 M | 87.6 M | 87.6 M | 87.6 M | 98.6 M | 98.6 M | 98.6 M | 98.6 M | 95.5 M | 95.5 M | 95.5 M | 95.5 M |
Cash and Cash Equivalents |
17.5 M | 17.3 M | 18.3 M | 18.5 M | 18.2 M | 16.4 M | 19.8 M | 19.5 M | 18.2 M | 17.3 M | 27 M | 25.8 M | 25.7 M | 24.9 M | 24.8 M | 24.8 M | 24.8 M | 24.8 M | 28.2 M | 27 M | 28.2 M | 24.6 M | 27.9 M | 27.9 M | 27.9 M | 27.9 M | 45.4 M | 45.4 M | 45.4 M | 45.4 M | 34.5 M | 34.5 M | 34.5 M | 34.5 M | 38.2 M | 38.2 M | 38.2 M | 38.2 M | 39.9 M | 39.9 M | 39.9 M | 39.9 M | 40.9 M | 40.9 M | 40.9 M | 40.9 M | 54.3 M | 54.3 M | 54.3 M | 54.3 M | 70.6 M | 70.6 M | 70.6 M | 70.6 M |
Book Value |
24.5 M | 26 M | 29.3 M | 35.7 M | 36.8 M | 36 M | 36 M | 38.5 M | 39.2 M | 40.8 M | 42.6 M | 46.6 M | 47.8 M | 46.9 M | 46.9 M | 46.9 M | 46.9 M | 46.9 M | 51.1 M | 51.7 M | 51.1 M | 55.2 M | 55.6 M | 55.6 M | 55.6 M | 55.6 M | 63.9 M | 63.9 M | 63.9 M | 63.9 M | 73.1 M | 73.1 M | 73.1 M | 73.1 M | 76.8 M | 76.8 M | 76.8 M | 76.8 M | 80.8 M | 80.8 M | 80.8 M | 80.8 M | 79.3 M | 79.3 M | 79.3 M | 79.3 M | 85.6 M | 85.6 M | 85.6 M | 85.6 M | 82.8 M | 82.8 M | 82.8 M | 82.8 M |
Total Shareholders Equity |
24.8 M | 26.3 M | 29.6 M | 35.7 M | 36.8 M | 36 M | 36.3 M | 38.9 M | 39.2 M | 40.8 M | 42.8 M | 46.6 M | 47.8 M | 46.9 M | 47 M | 47 M | 47 M | 47 M | 51.1 M | 51.7 M | 51.1 M | 55.4 M | 55.8 M | 55.8 M | 55.8 M | 55.8 M | 64.1 M | 64.1 M | 64.1 M | 64.1 M | 73.2 M | 73.2 M | 73.2 M | 73.2 M | 76.9 M | 76.9 M | 76.9 M | 76.9 M | 80.8 M | 80.8 M | 80.8 M | 80.8 M | 79.5 M | 79.5 M | 79.5 M | 79.5 M | 85.7 M | 85.7 M | 85.7 M | 85.7 M | 82.9 M | 82.9 M | 82.9 M | 82.9 M |
All numbers in USD currency